Suppr超能文献

左心室收缩功能障碍患者运动时的肺血管反应模式可预测运动能力和预后。

Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.

机构信息

Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, 02114, USA.

出版信息

Circ Heart Fail. 2011 May;4(3):276-85. doi: 10.1161/CIRCHEARTFAILURE.110.959437. Epub 2011 Feb 3.

Abstract

BACKGROUND

Elevated resting pulmonary arterial pressure (PAP) in patients with left ventricular systolic dysfunction (LVSD) purports a poor prognosis. However, PAP response patterns to exercise in LVSD and their relationship to functional capacity and outcomes have not been characterized.

METHODS AND RESULTS

Sixty consecutive patients with LVSD (age 60±12 years, left ventricular ejection fraction 0.31±0.07, mean±SD) and 19 controls underwent maximum incremental cardiopulmonary exercise testing with simultaneous hemodynamic monitoring. During low-level exercise (30 W), LVSD subjects, compared with controls, had greater augmentation in mean PAPs (15±1 versus 5±1 mm Hg), transpulmonary gradients (5±1 versus 1±1 mm Hg), and effective pulmonary artery elastance (0.05±0.02 versus -0.03±0.01 mm Hg/mL, P<0.0001 for all). A linear increment in PAP relative to work (0.28±0.12 mm Hg/W) was observed in 65% of LVSD patients, which exceeded that observed in controls (0.07±0.02 mm Hg/W, P<0.0001). Exercise capacity and survival was worse in patients with a PAP/watt slope above the median than in patients with a lower slope. In the remaining 35% of LVSD patients, exercise induced a steep initial increment in PAP (0.41±0.16 mm Hg/W) followed by a plateau. The plateau pattern, compared with a linear pattern, was associated with reduced peak Vo(2) (10.6±2.6 versus 13.1±4.0 mL · kg(-1) · min(-1), P=0.005), lower right ventricular stroke work index augmentation with exercise (5.7±3.8 versus 9.7±5.0 g/m(2), P=0.002), and increased mortality (hazard ratio 8.1, 95% CI 2.7 to 23.8, P<0.001).

CONCLUSIONS

A steep increment in PAP during exercise and failure to augment PAP throughout exercise are associated with decreased exercise capacity and survival in patients with LVSD, and may therefore represent therapeutic targets.

CLINICAL TRIAL INFORMATION

URL: http://www.clinicaltrials.gov. Unique identifier: NCT00309790.

摘要

背景

患有左心室收缩功能障碍(LVSD)的患者静息肺动脉压(PAP)升高表明预后不良。然而,LVSD 患者运动时的 PAP 反应模式及其与功能能力和结局的关系尚未确定。

方法和结果

连续 60 例 LVSD 患者(年龄 60±12 岁,左心室射血分数 0.31±0.07,均值±标准差)和 19 例对照者接受最大增量心肺运动试验,同时进行血流动力学监测。在低水平运动(30 W)时,与对照组相比,LVSD 患者的平均 PAP 增加幅度更大(15±1 对 5±1 mm Hg)、跨肺梯度更大(5±1 对 1±1 mm Hg)、有效肺动脉弹性更大(0.05±0.02 对-0.03±0.01 mm Hg/mL,均 P<0.0001)。65%的 LVSD 患者 PAP 相对于做功呈线性递增(0.28±0.12 mm Hg/W),高于对照组(0.07±0.02 mm Hg/W,P<0.0001)。PAP/瓦特斜率高于中位数的患者比斜率较低的患者运动能力和生存率更差。在剩余的 35%的 LVSD 患者中,运动引起的 PAP 初始急剧增加(0.41±0.16 mm Hg/W),随后出现平台。与线性模式相比,平台模式与峰值 Vo(2)降低(10.6±2.6 对 13.1±4.0 mL·kg(-1)·min(-1),P=0.005)、运动时右心室每搏功指数增加减少(5.7±3.8 对 9.7±5.0 g/m(2),P=0.002)和死亡率增加(风险比 8.1,95%CI 2.7 至 23.8,P<0.001)相关。

结论

LVSD 患者运动时 PAP 急剧增加且运动时 PAP 无法增加与运动能力下降和生存率降低相关,因此可能成为治疗靶点。

临床试验信息

网址:http://www.clinicaltrials.gov。唯一标识符:NCT00309790。

相似文献

1
Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes.
Circ Heart Fail. 2011 May;4(3):276-85. doi: 10.1161/CIRCHEARTFAILURE.110.959437. Epub 2011 Feb 3.
2
Prolonged mean VO2 response time in systolic heart failure: an indicator of impaired right ventricular-pulmonary vascular function.
Circ Heart Fail. 2013 May;6(3):499-507. doi: 10.1161/CIRCHEARTFAILURE.112.000157. Epub 2013 Apr 9.
5
Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.004082.
7
Pulse wave analysis of the aortic pressure waveform in severe left ventricular systolic dysfunction.
Circ Heart Fail. 2010 Jan;3(1):149-56. doi: 10.1161/CIRCHEARTFAILURE.109.862383. Epub 2009 Nov 10.
9
Left Ventricular Dysfunction and Exercise Capacity Trajectory: Implications for Subclinical Heart Failure Staging Criteria.
JACC Cardiovasc Imaging. 2019 May;12(5):798-806. doi: 10.1016/j.jcmg.2017.10.023. Epub 2018 Feb 14.
10

引用本文的文献

1
Determinants of cardiac output in health and heart failure.
Exp Physiol. 2025 May;110(5):637-648. doi: 10.1113/EP091505. Epub 2025 Mar 23.
2
Effects of Age and Sex on Systemic Inflammation and Cardiometabolic Function in Individuals With Type 2 Diabetes.
J Am Heart Assoc. 2025 Feb 4;14(3):e037863. doi: 10.1161/JAHA.124.037863. Epub 2025 Jan 23.
3
Combining cardiopulmonary exercise testing with echocardiography: a multiparametric approach to the cardiovascular and cardiopulmonary systems.
Eur Heart J Imaging Methods Pract. 2023 Aug 18;1(1):qyad021. doi: 10.1093/ehjimp/qyad021. eCollection 2023 May.
4
Exploring the Noninvasive Evaluation of the Pulmonary Pressure-Flow Relationship During Exercise.
J Am Heart Assoc. 2024 Aug 6;13(15):e036986. doi: 10.1161/JAHA.124.036986. Epub 2024 Jul 19.
6
The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension.
Eur Respir J. 2023 Oct 19;62(4). doi: 10.1183/13993003.00561-2023. Print 2023 Oct.
8
Prognostic Role of Metabolic Exercise Testing in Heart Failure.
J Clin Med. 2023 Jun 30;12(13):4438. doi: 10.3390/jcm12134438.
9
Role of Exercise Stress Echocardiography in Pulmonary Hypertension.
Life (Basel). 2023 Jun 14;13(6):1385. doi: 10.3390/life13061385.
10
Obesity-related heart failure with preserved ejection fraction: diagnostic and therapeutic challenges.
Korean J Intern Med. 2023 Mar;38(2):157-166. doi: 10.3904/kjim.2022.271. Epub 2023 Feb 6.

本文引用的文献

2
Right ventricular response to intensive medical therapy in advanced decompensated heart failure.
Circ Heart Fail. 2010 May;3(3):340-6. doi: 10.1161/CIRCHEARTFAILURE.109.900134. Epub 2010 Feb 22.
4
Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review.
Eur Respir J. 2009 Oct;34(4):888-94. doi: 10.1183/09031936.00145608. Epub 2009 Mar 26.
5
Exercise-induced pulmonary arterial hypertension.
Circulation. 2008 Nov 18;118(21):2183-9. doi: 10.1161/CIRCULATIONAHA.108.787101. Epub 2008 Nov 3.
6
Exercise blood pressure and the risk of incident cardiovascular disease (from the Framingham Heart Study).
Am J Cardiol. 2008 Jun 1;101(11):1614-20. doi: 10.1016/j.amjcard.2008.01.046. Epub 2008 Mar 28.
7
Effective arterial elastance as an index of pulmonary vascular load.
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2736-42. doi: 10.1152/ajpheart.00796.2007. Epub 2008 Apr 18.
9
Long-term use of sildenafil in the therapeutic management of heart failure.
J Am Coll Cardiol. 2007 Nov 27;50(22):2136-44. doi: 10.1016/j.jacc.2007.07.078. Epub 2007 Nov 13.
10
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Circulation. 2007 Oct 2;116(14):1555-62. doi: 10.1161/CIRCULATIONAHA.107.716373. Epub 2007 Sep 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验